Cite

HARVARD Citation

    Guo, B. et al. (2021). A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent. Journal of the Royal Statistical Society. 70 (5), pp. 1210-1229. [Online]. 
  
Back to record